We compared the impact of COX-2 versus mPGES-1 inhibition on human experimental tumor-associated immunity in an authentic in vitro tumor model composed of human MCF-7 breast cancer cells and human PBMCs. This evidence concerns the gene PTGS2 and breast cancer.